This Amedeo Smart survey is supported by AngelsInitiative.com.
AmedeoContraception and Contraceptive Drugs |
|
Free Subscription
Lancet |
- November 2025
- MEYER-RATH G, Jamieson L, Mudimu E, Snyman K, et al
Who pays and what pays off in sexual and reproductive health? A review of the cost and cost-effectiveness of interventions and implications for future funding and markets.
Lancet. 2025;406:2152-2167.
>> Share
- ANDERSON DJ, Bearak JM, Grimstad FW, Palanee-Phillips T, et al
Biomedical innovations in contraception: gaps, obstacles, and solutions for sexual and reproductive health.
Lancet. 2025;406:2119-2132.
>> Share
June 2025 - DE SMIT NS, de Lange ME, Boomsma MF, Huirne JAF, et al
Current treatment for symptomatic uterine fibroids: available evidence and therapeutic dilemmas.
Lancet. 2025 Jun 19:S0140-6736(25)00728-7. doi: 10.1016/S0140-6736(25)00728.
>> Share
August 2024 - RYDELIUS J, Hognert H, Kopp-Kallner H, Brandell K, et al
First dose of misoprostol administration at home or in hospital for medical abortion between 12-22 gestational weeks in Sweden (PRIMA): a multicentre, open-label, randomised controlled trial.
Lancet. 2024;404:864-873.
>> Share
August 2023 - CAHILL EP
Adding a COX-2 inhibitor improves efficacy of emergency contraception.
Lancet. 2023 Aug 16:S0140-6736(23)01612-4. doi: 10.1016/S0140-6736(23)01612.
>> Share
- LI RHW, Lo SST, Gemzell-Danielsson K, Fong CHY, et al
Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial.
Lancet. 2023 Aug 16:S0140-6736(23)01240-0. doi: 10.1016/S0140-6736(23)01240.
>> Share
June 2023 - MARSTON C, Tabot M
How can we put rights at the core of global family planning?
Lancet. 2023;401:2096-2098.
>> Share
May 2023 - MCCURRY J
Japan approves abortion pill.
Lancet. 2023;401:1558.
>> Share
April 2023 - JAFFE S
Drug developers caution against US mifepristone ban.
Lancet. 2023;401:1325-1326.
>> Share
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016
